- Company Overview for SPERO CANTAB UK LIMITED (10175336)
- Filing history for SPERO CANTAB UK LIMITED (10175336)
- People for SPERO CANTAB UK LIMITED (10175336)
- Registers for SPERO CANTAB UK LIMITED (10175336)
- More for SPERO CANTAB UK LIMITED (10175336)
Persons with significant control: 1 active person with significant control / 0 active statements
Spero Therapeutics, Inc. Active
- Correspondence address
- PO Box 02139, 675 Massachusetts Avenue, 14th Floor, Cambridge, Ma, United States
- Notified on
- 13 June 2017
- Governing law
- Legal form
- Public Limited Company
- Place registered
- Delaware
- Registration number
- 333220858
- Incorporated in
- United States
- Nature of control
- Ownership of voting rights - 75% or more
- Right to appoint or remove directors
Statement Withdrawn
- The company knows or has reasonable cause to believe that there is no registrable person or registrable relevant legal entity in relation to the company
- Notified on
- 10 May 2017
- Withdrawn on
- 13 June 2017